Time |
Room |
|
Activity |
08:00-09:30 | Room 1 - Alfredo Halpern | SESSION: ETHICS IN OBESITY TREATMENT 8 | Abstracts - 129096: THE EFFECT OF NEUROMODULATION WITH TRANSCRANIAL DIRECT CURRENT STIMULATION ON GLYCEMIC EXCURSION IN SUBJECTS WITH OVERWEIGHT AND OBESITY: A DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL - Presenter: Olavo da Silva Carvalho Porepp 20 | Differentiating “anti-obesity medications” from over the counter “weight loss supplements” 20 | Off label use of AOM´s: what are the options and when to use? 20 | Danger of unethical practices: from steroids to HCG 22 | Discussion |
08:00-09:30 | Room 2 - John Waterlow | SESSION: BODY COMPOSITION AND MUSCLE MASS: BEYOND THE OBVIOUS 08 | Abstracts - 129740: THE THERAPEUTIC POTENTIAL OF MICRORNA-22 IN MASH AND OBESITY - Presenter: Riccardo Panella 20 | Impact of sleep deprivation and disruption on body composition during weight loss treatments 20 | Effect of alcohol intake on BW and BC 20 | Body composition with Anti obesity medication 22 | Discussion |
08:00-09:30 | Room 3 - Bernard Jeanrenaud | SESSION: OBESITY AND TYPE 2 DIABETESCoordinator: João Eduardo Nunes Salles (SP) 20 | Role of the lymphatic system in visceral obesity and the metabolic syndrome 20 | Effects of obesity on beta-cellsSpeaker: Franco Folli (Italy) 20 | Weight dependent effects on diabetic kidney disease 30 | Discussion |
08:00-09:30 | Room 4 - Peter Kopelman | SESSION: OBESITY, VACCINES AND INFECTIONS 08 | Abstracts - 129003: BISPHENOL S IMPAIRS LIVER METABOLISM AND MORPHOLOGY IN MALE C57BL/6 MICE INDEPENDENT OF A HIGH-FAT DIET AND INDUCES HEPATOCYTE TOXICITY IN HUMAN HUH-7 HEPATOMA CELLS - Presenter: Abstracts - 129003: BISPHENOL S IMPAIRS LIVER METABOLISM AND MORPHOLOGY IN MALE C57BL/6 MICE INDEPENDENT OF A HIGH-FAT DIET AND INDUCES HEPATOCYTE TOXICITY IN HUMAN HUH-7 HEPATOMA CELLS - Time: 08 min. Presenter: Vinicius Sepúlveda Fragoso 20 | Influence of obesity on vaccine responses 20 | Obesity as a risk factor for severe viral infections: what´s the mechanism? 20 | Obesity as a risk factor for viral, bacterial and fungal diseases 22 | Discussion |
08:00-09:30 | Room 6 - Rafael Gomez-Cuevas | SESSION: ABSTRACTS - PUBLIC HEALTH 2 129067 - EFFECTIVENESS OF CANADIAN FRONT-OF-PACK LABELLING REGULATIONS AND CANADA’S FOOD GUIDE RECOMMENDATIONS IN IDENTIFYING ULTRA-PROCESSED FOODS 129250 - CHANGES IN THE HEALTHFULNESS OF FOOD AND BEVERAGE PURCHASES FROM 2006 TO 2020 IN FORMAL, MIXED, AND INFORMAL OUTLETS IN MEXICO 129703 - TIME TRENDS OF HYPERTENSION AND DIABETES AMONG ADULTS LIVING WITH OBESITY IN BRAZIL, 2006 TO 2023 129830 - IMPROVEMENTS IN THE GLOBAL DIET QUALITY SCORE IS ASSOCIATED WITH LOWER BODY WEIGHT GAIN, WAIST CIRCUMFERENCE, AND THE METABOLIC SYNDROME RISK - ELSA-BRASIL COHORT STUDY 129904 - GLOBAL ALLIANCE FOR CHILDREN’S HEALTHY DIETS: LATIN AMERICAN AND THE CARIBBEAN CHAPTER. STATE OF THE EVIDENCE. |
08:00-09:30 | Room 5 - Phillip James | SESSION: DIETARY GUIDELINES 20 | Methodology for Developing Healthy and Sustainable Dietary Guidelines in Mexico 20 | Canada’s Food Guide 2019 – Methods to evaluate adherence using different types of data 20 | A decade of the Brazilian Dietary Guidelines: contributions to obesity prevention, control, and health care 30 | Discussion |
09:30-10:30 | Room 3 - Bernard Jeanrenaud | KEYNOTE LECTURE: THE NUTRITIONAL ECOLOGY OF OBESITY |
09:30-10:30 | Room 2 - John Waterlow | MINI CONFERENCES 30 | Adipose Tissue Fibrosis in Obesity: Etiology and Challenges 30 | Choosing the right patient: can we predict who will benefit more from Bariatric surgery? |
09:30-10:30 | Room 1 - Alfredo Halpern | MINI CONFERENCE 30 | Creatine and other physical activity supplements in patients with obesity: when to use and when no to? 30 | The importance of melatonin in obesity and metabolic disorders |
09:30-10:30 | Room 5 - Phillip James | SESSION: OBESITY, PHYSICAL ACTIVITY, WELL-BEING AND MENTAL HEALTH Duração: 15 min. Duração: 15 min. Duração: 15 min. 15 | Discussion |
09:30-10:30 | Room 4 - Peter Kopelman | SESSION: CHANGING PERSPECTIVES 20 | Culinary Medicine: Education for Patients and HCPs for Therapeutic Lifestyle Changes 20 | Food in the future: how to balance individual health and planetary health? 20 | Home cooking as a strategy for a healthier life |
09:30-10:30 | Room 6 - Rafael Gomez-Cuevas | SESSION: AN INTRODUCTION TO SCOPESpeaker: Shubo Saiful (United Kingdom) |
10:30-11:00 | Room 1 - Alfredo Halpern | BREAK |
10:30-11:00 | Room 2 - John Waterlow | BREAK |
10:30-11:00 | Room 3 - Bernard Jeanrenaud | BREAK |
10:30-11:00 | Room 5 - Phillip James | BREAK |
10:30-11:00 | Room 4 - Peter Kopelman | BREAK |
11:00-12:30 | Room 2 - John Waterlow | SYMPOSIUM: STIGMA AND LANGUAGE IN OBESITY 08 | Abstracts - 129813: THE SPECIES ANAEROTRUNCUS COLIHOMINIS CORRELATES WITH ADIPOSITY, METABOLIC MARKERS, FOOD COMSUMPTION AND MENTAL HEALTH STATUS IN WOMEN WITH OBESITY, NORMAL WEIGHT, CONSTITUTIONAL THINNESS AND ANOREXIA NERVOSA - Presenter: Paula Waki Lopes da Rosa 20 | Obesity Stigma in Latin America: are there cultural differences? 20 | Compassion and Love in Obesity Management, what doctors are missing to treat patients long term 20 | Internalized stigma: what is it and how to manage it? 22 | Discussion |
11:00-12:30 | Room 1 - Alfredo Halpern | SESSION: DIET BEYOND WEIGHT LOSS 20 | What the evidence says about cardioprotective diets? 20 | Impact of nutrient intake in MASLD 20 | Gluten and lactose: myths, facts and presumptions 30 | Discussion |
11:00-12:30 | Room 3 - Bernard Jeanrenaud | SESSION: OVERCOMING OBESITY: THE ROLE OF MULTIPLE HORMONES IN ITS TREATMENT 15 | GLP1 and its effects on inflammation and CV protection beyond weight loss 15 | GIP:unveiling the mystery of its obesogenic versus weight reducing effectsSpeaker: Franco Folli (Italy) 15 | Glucagon: from a villain in diabetes to the “new kid on the block” 15 | Amylin: a phoenix returning from the ashes? 30 | Discussion |
11:00-12:30 | Room 5 - Phillip James | SESSION: CHILDHOOD OBESITY INTERVENTIONSCoordinator: Magdalena Wetzel (Argentina) 15 | Marketing directed at children 15 | The new obesity prevention strategy in Brazil and the school environment Duração: 15 min. 15 | Health systems interventions 30 | Discussion |
11:00-12:30 | Room 4 - Peter Kopelman | SESSION: WOMEN´S HEALTH 20 | The Impact of Estrogen and FSH on Energy Expenditure and weight change 20 | Hormonal replacement therapy in women with obesity: balancing risks and benefits 20 | The role of obesity treatment in fertility and metabolic outcomes in PCOS 30 | Discussion |
12:30-14:00 | Room 1 - Alfredo Halpern | BREAK |
12:30-14:00 | Room 2 - John Waterlow | BREAK |
12:30-14:00 | Room 3 - Bernard Jeanrenaud | BREAK |
12:30-14:00 | Room 5 - Phillip James | BREAK |
12:30-14:00 | Room 4 - Peter Kopelman | BREAK |
14:00-15:30 | Room 1 - Alfredo Halpern | SESSION: ADOLESCENT HEALTH 8 | Abstracts - 129804: ASSOCIATION OF METABOLIC HEALTH AND METABOLIC UNHEALTH OBESITY WITH HYPERGLYCEMIC CLAMP PARAMETERS IN ADOLESCENTS – BRAMS (BRAZILIAN METABOLIC SYNDROME STUDY) - Presenter: Abstracts - 129804: ASSOCIATION OF METABOLIC HEALTH AND METABOLIC UNHEALTH OBESITY WITH HYPERGLYCEMIC CLAMP PARAMETERS IN ADOLESCENTS – BRAMS (BRAZILIAN METABOLIC SYNDROME STUDY) - Time: 8 min. Presenter: Maria Eduarda Martelli 20 | Current and Future Pharmacotherapies for Obesity in Children and Adolescents 20 | Insulin resistance in puberty: physiology or pathology? 20 | Bariatric Surgery in Adolescents with obesity 22 | Discussion |
14:00-15:30 | Room 2 - John Waterlow | SESSION: TELEHEALTH AND DIGITAL TOOLS FOR OBESITY MANAGEMENT 8 | Abstracts - 129730: THE GLOBAL DIET QUALITY SCORE CORRELATION WITH KEY-NUTRIENTS INTAKE AND OTHER HEALTHY DIET METRICS IN BRAZIL – A NATION-WIDE REPRESENTATIVE STUDY - Presenter: Marina Maintinguer Norde 20 | Evidence for improving outcomes in treatment with telehealth 20 | Apps for the management of obesity: friend or foe? 20 | Artificial Intelligence in clinical practice and research: how the future looks like? 22 | Discussion |
14:00-15:30 | Room 3 - Bernard Jeanrenaud | SESSION: ORGAN-DAMAGE IN CHILDREN AND ADOLESCENTSCoordinator: Franco Folli (Italy) 20 | Type 2 diabetes in the Young: a fat driven agressive disease 20 | Hypothalamic/brain damage in childhood obesity 20 | Cardiac structural changes and athersclerosis in adolescents with obesity 30 | Discussion |
14:00-15:30 | Room 5 - Phillip James | SESSION: SHAPING THE NARRATIVE TO ADVANCE IN OBESITY PREVENTION POLICY Duração: 15 min.Speaker: Angelika Peczak (South Africa) Duração: 15 min. Duração: 15 min. Duração: 15 min.Speaker: Magdalena Wetzel (Argentina) Duração: 15 min. 15 | Discussion |
14:00-15:30 | Room 4 - Peter Kopelman | SESSION: ABESO-SBEM-SBCBM POSITION STATEMENT OF WEIGHT REGAIN AFTER BARIATRIC SURGERY |
14:00-15:30 | Room 6 - Rafael Gomez-Cuevas | SYMPOSIUM: LIPODYSTROPHY AND GENETIC CAUSES OF OBESITY: A LATIN AMERICAN PERSPECTIVE 20 | How LD study contribute to the understanding of the metabolic complications in obesity? 20 | Understanding the scenario of genetic lipodystrophies in Brazil 20 | Impact of leptin treatment on Monogenic Leptin Deficiency in a Latin American Family – early findings 30 | Discussion |
15:30-16:30 | Room 1 - Alfredo Halpern | AWARDS CEREMONY AND CLOSING CEREMONY |